Published on: October 19, 2020 at 09:30PM
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dulaglutide; Drug: Placebo; Drug: Insulin Glargine
Sponsor: Eli Lilly and Company
Not yet recruiting
https://ift.tt/3ke71en
Monday, 19 October 2020
New diabetes clinical trial: A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.